查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1663503

血管內治療設備市場，按產品、按程序、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Endovascular Treatment Devices Market, By Product, By Procedure, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年血管內治療設備市場規模價值為 34.5033 億美元，2025 年至 2032 年期間的複合年成長率為 9.50%。

血管內治療設備市場-市場動態

血管疾病盛行率不斷上升

由於人口老化、久坐的生活方式以及肥胖、高血壓和糖尿病等風險因素，血管疾病（包括周邊動脈疾病 (PAD)、主動脈瘤和靜脈血栓栓塞症 (VTE)）變得越來越普遍。根據世界衛生組織（WHO）的數據，心血管疾病（包括血管疾病）每年導致近1,790萬人死亡，佔全球死亡人數的32%。越來越多的患者需要有效的干涉來恢復血流並預防危及生命的併發症，從而增加了對先進治療方案的需求。血管內設備，例如支架移植物、球囊導管和血栓切除系統，為治療這些疾病提供了微創解決方案。它們比傳統的開放式手術更安全、更有效，減少了住院時間、恢復時間和術後併發症的風險。此外，政府改善醫療保健基礎設施和提高人們對血管疾病早期診斷和治療認知的措施進一步支持了市場擴張。例如，旨在降低心血管風險的國家健康運動和現代血管護理技術的整合正在促進成長。

血管內治療設備市場-關鍵見解

  • 根據我們的研究分析師的分析，預測期內（2025-2032 年），全球市場預計年複合成長率約為 9.50%
  • 根據產品細分，預計支架將在 2024 年佔據最大市場佔有率
  • 根據最終用戶細分，醫院是 2024 年的主要細分市場
  • 從地區來看，北美是 2024 年最大的收入來源

血管內治療設備市場-細分分析：

全球血管內治療設備市場根據產品、程序、最終用戶和地區進行細分。

根據產品，市場分為三類：支架、球囊導管和下腔靜脈過濾器。支架因其廣泛用於治療動脈阻塞，有效恢復血流並降低再狹窄風險而佔據市場主導地位。此外，藥物洗脫和生物可吸收支架的進步提高了長期效果，推動了它們繼續保持市場領先地位。

根據最終用戶，市場分為三類：醫院、門診手術中心、專科診所。醫院主導市場，因為它們配備了先進的醫療基礎設施、專門的血管護理單元以及複雜血管內手術所需的熟練專業人員。此外，更高的患者流量和術後護理設施的可用性使醫院成為血管治療的首選。

血管內治療設備市場-地理洞察

北美引領全球市場，這得益於血管疾病的高發性、先進的醫療保健系統以及微創手術的廣泛應用。據美國心臟協會稱，心血管疾病仍然是美國的主要死亡原因，這進一步推動了對創新血管內解決方案的需求。此外，優惠的報銷政策和持續的產品進步增強了該地區的主導地位。由於人口老化、醫療支出增加以及政府推動心血管疾病管理的舉措，歐洲佔據了相當大的市場佔有率。德國、英國和法國等國家憑藉其強大的醫療保健體系和醫療設備的技術進步做出了巨大貢獻。預計亞太地區將出現最快的成長，這得益於醫療保健意識的提高、周邊動脈疾病病例的增加以及醫療保健基礎設施的改善。中國、印度和日本等國家快速的城市化、生活方式的改變以及老齡人口的成長進一步促進了市場的擴張。此外，政府對現代醫療設施的投資和日益增多的醫療機會正在推動該地區的需求。

血管內治療設備市場-競爭格局：

血管內治療設備市場的競爭格局特徵是主要參與者之間的激烈競爭，重點在於創新、產品差異化和策略合作。各公司正大力投資研發，以推出安全性、有效性和耐用性更高的下一代設備，例如藥物洗脫和生物可吸收支架、先進的栓塞保護系統和新型血栓切除設備。市場參與者也在擴大其產品組合，以滿足針對不同血管疾病的微創解決方案日益成長的需求。策略夥伴關係、合併和收購是增強市場影響力、推動技術進步和擴大地理覆蓋範圍的常用策略。此外，參與者正在強調監管部門的批准和臨床試驗以獲得競爭優勢，同時滿足嚴格的安全標準並確保遵守全球醫療保健法規。人工智慧診斷和智慧血管內技術的日益普及正在塑造市場，為提高精準度和個人化治療創造機會。有競爭力的價格、強大的分銷網路和售後支援對於保持市場佔有率也發揮關鍵作用。隨著對先進血管治療解決方案的需求不斷成長，競爭強度預計也會上升，從而促進這一充滿活力的領域的持續創新和患者治療效果的改善。

最新動態：

  • 2024 年 6 月，波士頓科學公司宣布達成協議，收購 Silk Road Medical, Inc.，該公司專門生產頸動脈血管重建 (TCAR) 設備，這是一種旨在預防頸動脈疾病患者中風的微創手術。
  • 2024 年 7 月，Sensome 與日本 Cosmotec 簽署了其血凝感應導絲的獨家經銷協議。此次合作使 Cosmotec 能夠將 Sensome 的創新技術商業化，該技術旨在在血管內手術期間即時檢測血栓，改善臨床決策和患者預後。該協議標誌著 Sensome 向日本市場擴張邁出了重要一步，增強了其尖端醫療設備的獲取管道。
  • 2024年11月，Solaris Endovascular, Inc. 在美國成立，致力於開發末期腎臟病和周邊動脈疾病治療的透析解決方案。其旗艦產品 Solaris SX 血管支架移植物旨在利用先進的技術減少再狹窄並提高通暢率。

目錄

第 1 章：血管內治療設備市場概述

  • 研究範圍
  • 市場估計年限

第 2 章：執行摘要

  • 市場片段
    • 血管內治療設備市場（按產品）
    • 血管內治療設備市場片段（依程序）
    • 血管內治療設備市場片段（按最終用戶）
    • 血管內治療設備市場（按國家/地區）
    • 血管內治療設備市場片段（按地區）
  • 競爭洞察

第 3 章：血管內治療設備關鍵市場趨勢

  • 血管內治療設備市場促進因素
    • 市場促進因素的影響分析
  • 血管內治療設備市場限制
    • 市場限制的影響分析
  • 血管內治療設備的市場機會
  • 血管內治療設備市場未來趨勢

第 4 章：血管內治療設備產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景規劃
  • 規範架構分析

第5章：血管內治療設備市場：地緣政治張力升級的影響

  • 新冠肺炎疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第 6 章：血管內治療設備市場格局

  • 2024 年血管內治療設備市佔分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第 7 章：血管內治療設備市場 - 按產品分類

  • 概述
    • 按產品細分的佔有率分析
    • 支架
    • 球囊導管
    • 下腔靜脈過濾器
    • 其他

第 8 章：血管內治療設備市場 - 按程序

  • 概述
    • 按程序進行細分佔有率分析
    • 血管成形術
    • 動脈瘤修復
    • 血栓切除術
    • 其他

第 9 章：血管內治療設備市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 門診手術中心
    • 專科診所
    • 其他

第 10 章：血管內治療設備市場 - 按地區分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美血管內治療設備主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品分類）
    • 北美市場規模和預測，按程序
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲血管內治療設備主要製造商
    • 歐洲市場規模及預測（按國家）
    • 歐洲市場規模及預測（依產品分類）
    • 歐洲市場規模和預測，按程序
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區血管內治療設備主要製造商
    • 亞太地區市場規模及預測（依國家/地區分類）
    • 亞太地區市場規模及預測（依產品分類）
    • 亞太地區市場規模及預測（依流程分類）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲 (LATAM)
    • 概述
    • 拉丁美洲血管內治療設備主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品分類）
    • 拉丁美洲市場規模及預測（依流程分類）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲 (MEA)
    • 概述
    • 中東和非洲的血管內治療設備主要製造商
    • MEA 市場規模及預測（依國家/地區分類）
    • MEA 市場規模及預測（依產品分類）
    • MEA 市場規模和預測（按程序）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其他地區

第 11 章：主要供應商分析-血管內治療設備產業

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Boston Scientific Corporation
    • Medtronic plc
    • Abbott Laboratories
    • Johnson & Johnson Services, Inc.
    • Terumo Corporation
    • Cook Group Incorporated
    • Edwards Lifesciences Corporation
    • WL Gore & Associates, Inc.
    • Philips Healthcare
    • Siemens Healthineers
    • Cardinal Health
    • Stryker Corporation
    • Baxter International Inc.
    • Asahi Intecc Co., Ltd.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4673

REPORT HIGHLIGHT

Endovascular Treatment Devices Market size was valued at US$ 3,450.33 Million in 2024, expanding at a CAGR of 9.50% from 2025 to 2032.

Endovascular treatment devices are medical instruments used in minimally invasive procedures to treat various vascular diseases by accessing blood vessels through small incisions or punctures. These devices include stents, balloon catheters, embolic protection devices, and thrombectomy systems, which are essential for managing conditions like aneurysms, arterial blockages, and venous thromboembolism. Unlike traditional open surgeries, endovascular treatments offer a less invasive alternative, reducing patient trauma, hospital stays, and recovery times. The need for endovascular treatment devices arises from the growing prevalence of cardiovascular and peripheral vascular diseases driven by aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes. These devices enable precision-targeted interventions, improving clinical outcomes and patient safety. For example, stent grafts reinforce weakened blood vessels, preventing potentially fatal ruptures, while thrombectomy devices remove life-threatening blood clots with minimal risk. Their importance lies in transforming the management of complex vascular conditions. Endovascular procedures significantly reduce morbidity and mortality rates compared to conventional surgeries. They also lower healthcare costs by minimizing postoperative complications and facilitating faster recovery. Furthermore, technological advancements in device design and materials continue to enhance the effectiveness and durability of treatments, driving the adoption of endovascular solutions as a cornerstone in modern vascular care.

Endovascular Treatment Devices Market- Market Dynamics

Increasing prevalence of vascular diseases

Vascular conditions, including peripheral artery disease (PAD), aortic aneurysms, and venous thromboembolism (VTE), are becoming more widespread due to aging populations, sedentary lifestyles, and risk factors such as obesity, hypertension, and diabetes. According to the World Health Organization (WHO), cardiovascular diseases, which include vascular disorders, account for nearly 17.9 million deaths annually, representing 32% of all global deaths. A growing number of patients require effective interventions to restore blood flow and prevent life-threatening complications, increasing the demand for advanced treatment options. Endovascular devices, such as stent grafts, balloon catheters, and thrombectomy systems, offer minimally invasive solutions to manage these conditions. They provide a safer and more efficient alternative to traditional open surgeries, reducing hospital stays, recovery times, and the risk of postoperative complications. Furthermore, government initiatives to improve healthcare infrastructure and raise awareness about early diagnosis and treatment of vascular diseases further support market expansion. For example, national health campaigns targeting cardiovascular risk reduction and the integration of modern vascular care technologies are fostering growth.

Endovascular Treatment Devices Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.50% over the forecast period (2025-2032)
  • Based on Product segmentation, Stents was predicted to show maximum market share in the year 2024
  • Based on End-User segmentation, Hospitals was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Endovascular Treatment Devices Market- Segmentation Analysis:

The Global Endovascular Treatment Devices Market is segmented on the basis of Product, Procedure, End-User and Region.

The market is divided into three categories based on Product: Stents, Balloon Catheters and Inferior Vena Cava Filters. Stents dominate the market due to their widespread use in treating arterial blockages by restoring blood flow efficiently and reducing the risk of restenosis. Additionally, advancements in drug-eluting and bioresorbable stents enhance long-term outcomes, driving their continued market leadership.

The market is divided into three categories based on End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics. Hospitals dominate the market because they are equipped with advanced medical infrastructure, specialized vascular care units, and skilled professionals required for complex endovascular procedures. Additionally, the higher patient inflow and availability of post-operative care facilities make hospitals the preferred choice for vascular treatments.

Endovascular Treatment Devices Market- Geographical Insights

North America leads the global market, driven by a high incidence of vascular diseases, advanced healthcare systems, and widespread adoption of minimally invasive procedures. According to the American Heart Association, cardiovascular diseases remain a leading cause of death in the United States, further boosting the demand for innovative endovascular solutions. Additionally, favorable reimbursement policies and continuous product advancements strengthen the region's dominance. Europe holds a substantial market share, supported by an aging population, increased healthcare spending, and government initiatives promoting cardiovascular disease management. Countries like Germany, the United Kingdom, and France contribute significantly due to their robust healthcare systems and technological advancements in medical devices. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare awareness, increasing cases of peripheral artery diseases, and improvements in healthcare infrastructure. Rapid urbanization, lifestyle changes, and a growing elderly population in countries like China, India, and Japan further contribute to market expansion. Moreover, government investments in modern healthcare facilities and increasing access to medical treatments are propelling demand in this region.

Endovascular Treatment Devices Market- Competitive Landscape:

The competitive landscape of the endovascular treatment devices market is characterized by intense rivalry among key players focusing on innovation, product differentiation, and strategic collaborations. Companies are investing heavily in research and development to introduce next-generation devices with improved safety, efficacy, and durability, such as drug-eluting and bioresorbable stents, advanced embolic protection systems, and novel thrombectomy devices. Market participants are also expanding their portfolios to cater to the growing demand for minimally invasive solutions across diverse vascular conditions. Strategic partnerships, mergers, and acquisitions are common tactics to enhance market presence, drive technological advancements, and expand geographic reach. Additionally, players are emphasizing regulatory approvals and clinical trials to gain a competitive edge while meeting stringent safety standards and ensuring compliance with global healthcare regulations. The increasing adoption of AI-driven diagnostics and smart endovascular technologies is shaping the market, creating opportunities for enhanced precision and personalized treatment. Competitive pricing, robust distribution networks, and post-sales support also play critical roles in maintaining market share. As the demand for advanced vascular treatment solutions grows, the competitive intensity is expected to rise, fostering continuous innovation and improved patient outcomes in this dynamic sector.

Recent Developments:

  • In June 2024, Boston Scientific announced an agreement to acquire Silk Road Medical, Inc., a company specializing in devices for transcarotid artery revascularization (TCAR), a minimally invasive procedure aimed at preventing strokes in patients with carotid artery disease.
  • In July 2024, Sensome signed an exclusive distribution agreement with Cosmotec in Japan for its clot-sensing guidewire. This partnership allows Cosmotec to commercialize Sensome's innovative technology, which is designed to detect blood clots in real time during endovascular procedures, improving clinical decision-making and patient outcomes. The agreement marks an important step in Sensome's expansion into the Japanese market, enhancing access to its cutting-edge medical devices.
  • In November 2024, Solaris Endovascular, Inc. has launched in the U.S. to develop solutions for dialysis access in end-stage kidney disease and peripheral artery disease treatment. Its flagship product, the Solaris SX vascular stent graft, aims to reduce restenosis and improve patency with advanced technology.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Boston Scientific Corporation
  • Medtronic plc
  • Abbott Laboratories
  • Johnson & Johnson Services, Inc.
  • Terumo Corporation
  • Cook Group Incorporated
  • Edwards Lifesciences Corporation
  • W. L. Gore & Associates, Inc.
  • Philips Healthcare
  • Siemens Healthineers
  • Cardinal Health
  • Stryker Corporation
  • Baxter International Inc.
  • Asahi Intecc Co., Ltd.
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Stents
  • Balloon Catheters
  • Inferior Vena Cava Filters
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY PROCEDURE - MARKET ANALYSIS, 2019 - 2032

  • Angioplasty
  • Aneurysm Repair
  • Thrombectomy
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

GLOBAL ENDOVASCULAR TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Endovascular Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Endovascular Treatment Devices Market Snippet by Product
    • 2.1.2. Endovascular Treatment Devices Market Snippet by Procedure
    • 2.1.3. Endovascular Treatment Devices Market Snippet by End-User
    • 2.1.4. Endovascular Treatment Devices Market Snippet by Country
    • 2.1.5. Endovascular Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Endovascular Treatment Devices Key Market Trends

  • 3.1. Endovascular Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Endovascular Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Endovascular Treatment Devices Market Opportunities
  • 3.4. Endovascular Treatment Devices Market Future Trends

4. Endovascular Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Endovascular Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Endovascular Treatment Devices Market Landscape

  • 6.1. Endovascular Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Endovascular Treatment Devices Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Stents
    • 7.1.3. Balloon Catheters
    • 7.1.4. Inferior Vena Cava Filters
    • 7.1.5. Others

8. Endovascular Treatment Devices Market - By Procedure

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 8.1.2. Angioplasty
    • 8.1.3. Aneurysm Repair
    • 8.1.4. Thrombectomy
    • 8.1.5. Others

9. Endovascular Treatment Devices Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory Surgical Centers
    • 9.1.4. Specialty Clinics
    • 9.1.5. Others

10. Endovascular Treatment Devices Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Endovascular Treatment Devices Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Endovascular Treatment Devices Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Endovascular Treatment Devices Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Endovascular Treatment Devices Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Endovascular Treatment Devices Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Endovascular Treatment Devices Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Boston Scientific Corporation
    • 11.2.2. Medtronic plc
    • 11.2.3. Abbott Laboratories
    • 11.2.4. Johnson & Johnson Services, Inc.
    • 11.2.5. Terumo Corporation
    • 11.2.6. Cook Group Incorporated
    • 11.2.7. Edwards Lifesciences Corporation
    • 11.2.8. W. L. Gore & Associates, Inc.
    • 11.2.9. Philips Healthcare
    • 11.2.10. Siemens Healthineers
    • 11.2.11. Cardinal Health
    • 11.2.12. Stryker Corporation
    • 11.2.13. Baxter International Inc.
    • 11.2.14. Asahi Intecc Co., Ltd.
    • 11.2.15. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us